CG
EBS icon

Cutler Group’s Emergent Biosolutions EBS Stock Holding History

Cutler Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-900
Closed -$3K – 4577
2022
Q3 		$3K Sell
900
-1,900
-68% -$52.9K ﹤0.01% 3936
2022
Q2 		$7K Buy
+2,800
New +$95.6K ﹤0.01% 3450
2021
Q1 		– Sell
-400
Closed -$4K – 5775
2020
Q4 		$4K Buy
+400
New +$36.7K ﹤0.01% 3769
2017
Q1 		– Sell
-5,000
Closed -$10K – 6550
2016
Q4 		$10K Sell
5,000
-2,300
-32% -$69K ﹤0.01% 4183
2016
Q3 		$23K Sell
7,300
-8,700
-54% -$253K ﹤0.01% 3275
2016
Q2 		$50K Buy
+16,000
New +$627K ﹤0.01% 2349

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cutler Group's EBS Position: Q4 2022 in Review

Cutler Group sold out of Emergent Biosolutions (EBS) in Q4 2022, closing a stake of 203 shares — an estimated $4K sold.

Cutler Group first reported a position in EBS in Q2 2016 and held it in 10 quarters. The position peaked at $99K in Q4 2020. 198 funds tracked by Wall St. Rank hold EBS as of Q4 2022.

  • Cutler Group reported no remaining Emergent Biosolutions position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 203 Emergent Biosolutions shares in Q4 2022, an estimated $4K.
  • Cutler Group first reported a position in Emergent Biosolutions in Q2 2016 and held it in 10 quarters.
  • Cutler Group's Emergent Biosolutions position peaked at $99K in Q4 2020.
  • 198 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.